Trial record 2 of 4 for:
Ventyx
VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis (Serenity PsO)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05655299 |
|
Recruitment Status :
Terminated
(Business Decision)
First Posted : December 19, 2022
Last Update Posted : December 28, 2023
|
Sponsor:
Ventyx Biosciences, Inc
Information provided by (Responsible Party):
Ventyx Biosciences, Inc
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | September 13, 2023 |
| Actual Study Completion Date : | December 20, 2023 |